Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma Of Esophagus × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1

Interventions

Radiotherapy 22 Fluorouracil 18 Oxaliplatin 17 Leucovorin 13 Cisplatin 13 Paclitaxel 10 Radiation 8 Irinotecan 8 Docetaxel 7 Capecitabine 7 Cetuximab 6 Carboplatin 6 pembrolizumab 5 Trastuzumab 4 Taxes 4 Neoadjuvant Therapy 4 Panitumumab 3 Folfox protocol 3 Chemotherapy, Adjuvant 3 Biopsy 3 tucatinib 2 Surgical Procedures, Operative 2 Reverse Transcriptase Polymerase Chain Reaction 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Immunohistochemistry 2 Gefitinib 2 Erlotinib Hydrochloride 2 Epirubicin 2 Endoscopy, Digestive System 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡